0
Skip to Content
Goldenrod Therapeutics
Home
About
Science
Development
News
Contact Us
Goldenrod Therapeutics
Home
About
Science
Development
News
Contact Us
Home
About
Science
Development
News
Contact Us

2024: Fannin Innovation Studio Accepted Into NIDA's Medications Discovery Program

Award
Oct 3
Written by Fannin Website
Fannin Website
Previous
Previous

2024: Fannin Partners Secures Grant Funding from NIDA and DoD to Advance Novel PDE4B Inhibitors for Neurological Diseases

Next
Next

11h data presented at the ISAM World Congress


Privacy Policy‍ ‍Terms & Conditions

© Goldenrod 2026